In line with these findings, we further provided evidence that restoration of ATF4 expression by CK1δ activation inhibition or proteasomal degradation inhibitor successfully enhances cisplatin‐induced toxicity in gastric cancer. The gene discussed is ATF4; the disease is gastric cancer.